Exchange: NASDAQ·Updated 12:07 PM EDT
TIVC logo

TIVCTivic Health Systems Inc

$0.29
$0.021
(6.75%)
Today
Mkt Cap$1.29M
Vol2.75M
News
all
press releases
Tivic Health Systems (TIVC) Stock Surges Over 24% After Hours: Here's What Is Happening
Tivic Health Systems Inc. shares rise 24.10% after hours after announcing a full rebrand to Valion Bio and a strategic pivot toward Entolimod-based immunotherapy development.read more...
Benzinga
More News
Tivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream Model
Tivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream Model...
PR Newswire
Sheryle Bolton Purchases 10,000 Shares of Tivic Health Systems (NASDAQ:TIVC) Stock
Tivic Health Systems, Inc. (NASDAQ:TIVC - Get Free Report) Director Sheryle Bolton acquired 10,000 shares of Tivic Health Systems stock in a transaction on Wednesday, April 15th. The shares were...
MarketBeat
Tivic Health Selected to Present Entolimod as a Radiation Countermeasure and its Plans for an Oral Transmucosal Program to the Department of War Tech Watch Program on May 7th
Tivic Health Selected to Present Entolimod as a Radiation Countermeasure and its Plans for an Oral Transmucosal Program to the Department of War Tech Watch Program on May 7th Tivic Health Selected to...
PR Newswire
Tivic Health Systems (NASDAQ:TIVC) Director Christina Rizopoulos Valauri Acquires 19,000 Shares
Tivic Health Systems, Inc. (NASDAQ:TIVC - Get Free Report) Director Christina Rizopoulos Valauri purchased 19,000 shares of Tivic Health Systems stock in a transaction dated Wednesday, April 1st. The shares were purchased at an average cost of $0.95 per share, for a total transaction of $18,050.00...
MarketBeat
Tivic Expands Intellectual Property Portfolio
Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, today announced it is expanding its intellectual property portfolio with the recent filing of two additional patent...
Business Wire
Tivic Health to Report Third Quarter 2025 Financial Results on November 14th Via Conference Call and Webcast
Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that it will report its third quarter results for 2025 via pre-recorded conference call and...
Business Wire
Tivic CEO, Jennifer Ernst, to Join Panel at 8th Annual Northwell Health Innovation Constellation Forum on Thursday, Oct. 23
Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that CEO, Jennifer Ernst, will participate in the eighth annual Constellation Forum, a global...
Business Wire
Tivic Receives Two Investigational New Drug Applications for Entolimod for the Treatment of Acute Radiation Syndrome (ARS) and Advanced Cancers
Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced it has received, from Statera Biopharma, two investigational new drug applications (INDs) for its...
Business Wire
Tivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025
Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, is proud to announce it advanced discussions with key US Government agencies through its participation in the 2025...
Business Wire
<
1
2
...
>

Advertisement|Remove ads.